¼¼°èÀÇ ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå ºÐ¼® : ¿ëµµº°, Á¦Ç°º°, ±¹°¡º° ºÐ¼® ¹× ¿¹Ãø(2025-2034³â)
White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034
»óǰÄÚµå
:
1757393
¸®¼Ä¡»ç
:
BIS Research Inc.
¹ßÇàÀÏ
:
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ê¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö·Îµµ ¾Ë·ÁÁø ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö´Â »ì¾ÆÀÖ´Â ¼¼Æ÷, È¿¼Ò ¹× ¹ßÈ¿ °úÁ¤À» Ȱ¿ëÇÏ¿© ¹ÙÀÌ¿À ±â¹Ý ÈÇй°Áú, Àç·á ¹× ¿¡³ÊÁö ¿î¹Ýü¸¦ »ý»êÇÏ´Â ±â¼úÀÔ´Ï´Ù.
ÁÖ¿ä ¿ëµµ ºÐ¾ß¿¡´Â ¹ÙÀÌ¿À¿¬·á(°í±Þ ¹ÙÀÌ¿ÀµðÁ© ¹× ¹ÙÀÌ¿À¿¡Åº¿Ã µî), »ýÈÇй°Áú(À¯±â»ê, ¿ë¸Å), »ê¾÷¿ë È¿¼Ò(¼¼Á¦, ¼¶À¯, ½Äǰ °¡°ø¿ë), ¹ÙÀÌ¿À¼ÒÀç(¹ÙÀÌ¿ÀÆú¸®¸Ó, ¹ÙÀÌ¿ÀÇÃ¶ó½ºÆ½) ¹× ¹ÙÀÌ¿Àº¹¿ø ¹× Àç»ý °¡´ÉÇÑ ¿ø·á °¡Ä¡È µî ½ÅÈï ºÐ¾ß°¡ Æ÷ÇԵ˴ϴÙ. ÇÕ¼º ¹ÙÀÌ¿ÀÇÐ, ´ë»ç °øÇÐ, ´Ü¹éÁú °øÇÐ ºÐ¾ßÀÇ ±â¼úÀû ¹ßÀüÀº ´õ È¿À²ÀûÀÎ ±ÕÁÖ °³¹ß, ³ôÀº ¼öÀ², °øÁ¤ ºñ¿ë Àý°¨À» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ µðÁöÅÐ µµ±¸(¹ÙÀÌ¿À°øÁ¤ ÃÖÀûȸ¦ À§ÇÑ ¸Ó½Å·¯´×, °íÈ¿À² ½ºÅ©¸®´×, È®Àå °¡´ÉÇÑ ¿¬¼Ó À¯µ¿ ¹ßÈ¿)´Â ½Å±Ô ¹ÙÀÌ¿ÀÁ¦Ç°ÀÇ ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃà½Ã۰í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÇаú µðÁöÅÐÈÀÇ À¶ÇÕÀº ¹é»ö ¹ÙÀÌ¿À°øÇÐ ½ÃÀåÀ» Æ´»õ Ư¼ö ÀÀ¿ë ºÐ¾ß·ÎºÎÅÍ ´ë±Ô¸ð »ê¾÷Àû äÅÃÀ¸·ÎÀÇ ÀüȯÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ½ÃÀå Åë°è |
¿¹Ãø ±â°£ |
2025-2034³â |
Æò°¡(2025³â) |
3,375¾ï 6,000¸¸ ´Þ·¯ |
2034³â ¿¹Ãø |
6,729¾ï 2,000¸¸ ´Þ·¯ |
CAGR |
7.97% |
ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀåÀº °·ÂÇÑ ¿¬±¸°³¹ß ÅõÀÚ, ±â¼ú »ó¿ëÈÀÇ °¡¼ÓÈ, ±âÁ¸ ÈÇÐ »ê¾÷ ±â¾÷°ú À¯¿¬ÇÑ ¹ÙÀÌ¿ÀÅ×Å© ½ºÅ¸Æ®¾÷ÀÇ ±â¹Ý È®´ë¸¦ Ư¡À¸·Î ÇÏ´Â ¼ºÀå ´Ü°è¿¡ ÀÖ½À´Ï´Ù. ½ÃÀå ÁýÁßµµ´Â Áß°£ ¼öÁØÀ̸ç, Çõ½ÅÀº ³ëº¸ÀÚÀÓ½º¿Í µàÆù °°Àº È¿¼Ò »ý»ê¾÷üºÎÅÍ ¹ÙÀÌ¿À ±â¹Ý Àç·á ¼±±¸ÀÚ±îÁö ´Ù¾çÇÑ ºÎ¹®¿¡ ºÐ»êµÇ¾î ÀÖ¾î ½Å±Ô ÁøÀÔÀÚ¿¡°Ô ÃæºÐÇÑ ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. °øÁ¤ È¿À²¼ºÀÌ Çâ»óµÇ°í ¹ÙÀÌ¿À ±â¹Ý Á¦Ç°¿¡ ´ëÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¼º¼÷ÇÔ¿¡ µû¶ó, ÇØ´ç »ê¾÷Àº ÇâÈÄ 10³â°£ ÅëÇÕ°ú ¼º¼÷ ´Ü°è·Î ÀüȯµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ´ë±Ô¸ð Àü·«Àû ÆÄÆ®³Ê½Ê°ú ÇÕº´ÀÌ °æÀï ±¸µµ¸¦ Çü¼ºÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.
ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀåÀÇ ¼¼ºÐÈ
¼¼ºÐÈ 1 : ¿ëµµº°
- ¹ÙÀÌ¿À¿¡³ÊÁö
- ½Äǰ, »ç·á ÷°¡¹°
- ÀǾàǰ ¿ø·á
- ÆÛ½º³ÎÄÉ¾î ¹× °¡Á¤¿ëǰ
- ±âŸ
¹ÙÀÌ¿À¿¡³ÊÁö´Â ¼¼°èÀÇ ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå¿¡¼ ½ÃÀåÀÇ ÁÖ¿ä ÀÀ¿ë ºÐ¾ß Áß ÇϳªÀÔ´Ï´Ù.
¼¼ºÐÈ 2 : Á¦Ç° À¯Çüº°
- »ýÈÇÐ
- ¹ÙÀÌ¿À¿¬·á
- ¹ÙÀÌ¿À ±â¹Ý Àç·á
- ¹ÙÀÌ¿À ±â¹Ý Á¦Ç°
¼¼°èÀÇ ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀåÀº Á¦Ç° À¯Çüº°·Î »ýÈÇÐ ºÎ¹®ÀÌ °ßÀÎÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
¼¼ºÐÈ 3 : Áö¿ªº°
- ºÏ¹Ì - ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ
- À¯·´ - µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹, ±âŸ
- ¾Æ½Ã¾ÆÅÂÆò¾ç - Áß±¹, ÀϺ», Çѱ¹, Àεµ µî
- ±âŸ - ³²¹Ì, Áßµ¿, ¾ÆÇÁ¸®Ä«
ÈÀÌÆ®¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå¿¡¼´Â ºÏ¹Ì´Â Àç»ý °¡´É ÀÚ¿ø ¼ö¿ä Áõ°¡¿Í Á¤ºÎ Á¤Ã¥À¸·Î ÀÎÇØ »ý»ê Ãø¸é¿¡¼ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼ö¿ä - ÃËÁø¿äÀΰú ÇѰè
´ÙÀ½Àº ¼¼°èÀÇ ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå ¼ö¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.
- Àç»ý °¡´É ÀÚ¿øÀ» ÇâÇÑ ¼ö¿ä Áõ°¡
¼¼°èÀÇ ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀåÀº ´ÙÀ½°ú °°Àº °úÁ¦·Î ÀÎÇØ ¸î °¡Áö ÇѰ迡 Á÷¸éÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷°ú °æÀï ±¸µµ
ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå °æÀï ºÎ¹®Àº ±âÁ¸ ÈÇÐ ¹× »ý¸í°úÇÐ ±â¾÷°ú Àü¹® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö Çõ½Å ±â¾÷µéÀÇ ÆÄµµ·Î Ư¡Áö¾îÁö´Â ´Ù¾çÇÑ °æÀï ȯ°æÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷ÀÎ Novozymes A/S, DuPont de Nemours, BASF SE, Evonik Industries AG µîÀº ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) ¿ª·®°ú ±Û·Î¹ú »ý»ê ³×Æ®¿öÅ©¸¦ Ȱ¿ëÇØ »ê¾÷¿ë È¿¼Ò, »ý¹° ±â¹Ý Æú¸®¸Ó ¹× Ư¼ö »ýÈÇÐ ¹°ÁúÀ» ´ë·®À¸·Î °ø±ÞÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, Amyris Inc., Genomatica Inc., Codexis Inc. ¹× Ginkgo Bioworks¿Í °°Àº À¯¿¬¼º ÀÖ´Â ¼ø¼ö ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â¾÷µéÀº °í±Þ ´ë»ç °øÇÐ, µ¶Á¡ÀûÀÎ ±ÕÁÖ °³¹ß Ç÷§Æû ¹× µðÁöÅÐ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÃÖÀûÈ µµ±¸¸¦ ÅëÇØ ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇÏ°í ´ÜÀ§ ºñ¿ëÀ» Àý°¨ÇÔÀ¸·Î½á Â÷º°È¸¦ ¸ð»öÇϰí ÀÖ½À´Ï´Ù. Áß°£ ±Ô¸ð ±â¾÷ÀÎ Archer Daniels Midland, Cargill Incorporated, Corbion N.V. ¹× Lonza Group Ltd.´Â ¿ø·á ÅëÇÕ ¹× ¼øÈ¯ °æÁ¦ ¼Ö·ç¼Ç¿¡¼ °æÀïÇϰí ÀÖÀ¸¸ç, Ȱ¹ßÇÑ M&A ȯ°æ°ú ÈÇÐ ´ë±â¾÷°ú ¹ÙÀÌ¿ÀÅ×Å© ½ºÅ¸Æ®¾÷ °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº ½ÃÀå Á¡À¯À²À» ÀçÆíÇϰí ÅëÇÕÀ» ÃËÁøÇϸç Â÷¼¼´ë ±â¼ú ÀÌÀüÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°èÀÇ ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ¿ëµµº°, Á¦Ç°º°, ±¹°¡º° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
ÁÖ¿ä ¿ä¾à
Á¦1Àå ½ÃÀå : ¾÷°è Àü¸Á
- µ¿Çâ : Çö»ó°ú Àå·¡¿¡ ´ëÇÑ ¿µÇâ Æò°¡
- ÀÌÇØ°ü°èÀÚ ºÐ¼®
- ÀÌ¿ë »ç·Ê
- ÃÖÁ¾ »ç¿ëÀÚ¿Í ±¸¸Å ±âÁØ
- ½ÃÀå ¿ªÇÐ °³¿ä
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ÅõÀÚ »óȲ°ú ¿¬±¸ °³¹ß µ¿Çâ
- Àü¸Á°ú ½ÃÀå ·Îµå¸Ê
Á¦2Àå ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå(¿ëµµº°)
- ¿ëµµÀÇ ¼¼ºÐÈ
- ¿ëµµÀÇ ¿ä¾à
- ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå(¿ëµµº°)
- ¹ÙÀÌ¿À¿¡³ÊÁö
- ½Äǰ, »ç·á ÷°¡¹°
- ÀǾàǰ ¿ø·á
- ÆÛ½º³ÎÄɾî Á¦Ç°°ú °¡Á¤¿ëǰ
- ±âŸ
Á¦3Àå ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå(Á¦Ç°º°)
- Á¦Ç°ÀÇ ¼¼ºÐÈ
- Á¦Ç° ¿ä¾à
- ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå(Á¦Ç° À¯Çüº°)
- »ýÈÇÐ
- ¹ÙÀÌ¿À¿¬·á
- ¹ÙÀÌ¿À ±â¹Ý Àç·á
- ¹ÙÀÌ¿À ±â¹Ý Á¦Ç°
Á¦4Àå ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå(Áö¿ªº°)
- ÈÀÌÆ® ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½ÃÀå(Áö¿ªº°)
- ºÏ¹Ì
- Áö¿ª °³¿ä
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ÁÖ¿ä ±â¾÷
- ¿ëµµ
- Á¦Ç°
- ºÏ¹Ì(±¹°¡º°)
- À¯·´
- Áö¿ª °³¿ä
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ÁÖ¿ä ±â¾÷
- ¿ëµµ
- Á¦Ç°
- À¯·´(±¹°¡º°)
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áö¿ª °³¿ä
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ÁÖ¿ä ±â¾÷
- ¿ëµµ
- Á¦Ç°
- ¾Æ½Ã¾ÆÅÂÆò¾ç(±¹°¡º°)
- ±âŸ Áö¿ª
- Áö¿ª °³¿ä
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ÁÖ¿ä ±â¾÷
- ¿ëµµ
- Á¦Ç°
- ±âŸ Áö¿ª(Áö¿ªº°)
Á¦5Àå ½ÃÀå : °æÀï º¥Ä¡¸¶Å· ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ
- ÇâÈÄ Àü¸Á
- Áö¸®Àû Æò°¡
- ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Medtronic
- Novozymes
- BASF SE
- DuPont
- Cargill, Inc.
- Royal DSM NV
- Archer Daniles Midland Company
- BioAmber Inc.
- Lesaffre
- Corbion NV
- Evonik Industries AG
- Genomatica, Inc
- Ginkgo Bioworks
- Amyris Inc.
- TerraVia Holdings, Inc
- ±âŸ ÁÖ¿ä ±â¾÷
Á¦6Àå Á¶»ç ¹æ¹ý
HBR
¿µ¹® ¸ñÂ÷
Global White Biotechnology Market: Industry Overview
White biotechnology also known as industrial biotechnology leverages living cells, enzymes and fermentation processes to produce bio-based chemicals, materials and energy carriers. Core application areas include biofuels (e.g., advanced biodiesel and bioethanol), biochemicals (organic acids, solvents), industrial enzymes (for detergents, textiles, food processing), biomaterials (biopolymers, bioplastics) and emerging fields such as bioremediation and renewable feedstock valorization. Technological advances in synthetic biology, metabolic engineering and protein engineering are enabling more efficient strain development, higher yields and reduced process costs. Concurrently, digital tools-machine learning for bioprocess optimization, high-throughput screening and scalable continuous-flow fermentation-are accelerating time-to-market for new bioproducts. This convergence of biology and digitalization is driving white biotechnology market's transformation from niche specialty applications toward large-scale industrial adoption.
White Biotechnology Market Lifecycle Stage
KEY MARKET STATISTICS |
Forecast Period | 2025 - 2034 |
2025 Evaluation | $337.56 Billion |
2034 Forecast | $672.92 Billion |
CAGR | 7.97% |
The white biotechnology market is firmly in its growth phase, characterized by robust R&D investment, rapid technology commercialization and an expanding base of both established chemical-industry incumbents and agile biotech startups. Market concentration remains moderate, with innovation dispersed across diverse segments-from enzyme producers like Novozymes and DuPont to bio-based materials pioneers-indicating ample room for new entrants. As process efficiencies improve and regulatory frameworks for bio-based products mature, the industry is poised to transition toward consolidation and maturation over the next decade, with large strategic partnerships and mergers likely to shape the competitive landscape.
White Biotechnology Market Segmentation:
Segmentation 1: by Application
- Bioenergy
- Food and Feed Additives
- Pharmaceutical Ingredients
- Personal Care and Household Products
- Others
Bioenergy is one of the prominent application segments in the global white biotechnology market.
Segmentation 2: by Product Type
- Biochemical
- Biofuel
- Biomaterial
- Bioproduct
The global white biotechnology market is estimated to be led by the biochemical segment in terms of product type.
Segmentation 3: by Region
- North America - U.S., Canada, and Mexico
- Europe - Germany, France, Italy, Spain, U.K., and Rest-of-Europe
- Asia-Pacific - China, Japan, South Korea, India, and Rest-of-Asia-Pacific
- Rest-of-the-World - South America and Middle East and Africa
In the white biotechnology market, North America is anticipated to gain traction in terms of production, with increasing demand towards renewable resources and govement initiatives.
Demand - Drivers and Limitations
The following are the demand drivers for the global white biotechnology market:
- Increasing Demand Towards Renewable Resources
The global white biotechnology market is expected to face some limitations as well due to the following challenges:
- High Initial Investment Costs
White Biotechnology Market Key Players and Competition Synopsis
The white biotechnology market sector is characterized by a diverse competitive landscape dominated by established chemical and life-sciences firms alongside a wave of specialized biotech innovators. Leading companies-such as Novozymes A/S, DuPont de Nemours, BASF SE, Evonik Industries AG-leverage extensive R&D capabilities and global production networks to supply industrial enzymes, bio-based polymers and specialty biochemicals at scale. At the same time, agile pure-play biotechnology companies-Amyris Inc., Genomatica Inc., Codexis Inc. and Ginkgo Bioworks-are differentiating themselves through advanced metabolic engineering, proprietary strain-development platforms and digital bioprocess optimization tools that accelerate time-to-market and reduce unit costs. Mid-tier players including Archer Daniels Midland, Cargill Incorporated, Corbion N.V. and Lonza Group Ltd. compete on feedstock integration and circular-economy solutions, while an active M&A environment and strategic partnerships-linking chemical giants with biotech startups-continue to reshape market share, drive consolidation and foster next-generation technology transfer.
Some prominent names established in the white biotechnology market are:
- Medtronic
- Novozymes
- BASF SE
- DuPont
- Cargill, Inc.
- Royal DSM N.V.
- Archer Daniles Midland Company
- BioAmber Inc.
- Lesaffre
- Corbion N.V.
- Evonik Industries AG
- Genomatica, Inc
- Ginkgo Bioworks
- Amyris Inc.
- TerraVia Holdings, Inc
Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).
Table of Contents
Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1. Markets: Industry Outlook
- 1.1 Trends: Current and Future Impact Assessment
- 1.2 Stakeholder Analysis
- 1.2.1 Use Case
- 1.2.2 End User and Buying Criteria
- 1.3 Market Dynamics Overview
- 1.3.1 Market Drivers
- 1.3.2 Market Restraints
- 1.3.3 Market Opportunities
- 1.4 Investment Landscape and R&D Trends
- 1.5 Future Outlook and Market Roadmap
2. White Biotechnology Market (by Application)
- 2.1 Application Segmentation
- 2.2 Application Summary
- 2.3 White Biotechnology Market (by Application)
- 2.3.1 Bioenergy
- 2.3.2 Food and Feed Additives
- 2.3.3 Pharmaceutical Ingredients
- 2.3.4 Personal Care and Household Products
- 2.3.5 Others
3. White Biotechnology Market (by Product)
- 3.1 Product Segmentation
- 3.2 Product Summary
- 3.3 White Biotechnology Market (by Product Type)
- 3.3.1 Biochemical
- 3.3.2 Biofuel
- 3.3.3 Biomaterial
- 3.3.4 Bioproduct
4. White Biotechnology Market (by Region)
- 4.1 White Biotechnology Market (by Region)
- 4.2 North America
- 4.2.1 Regional Overview
- 4.2.2 Driving Factors for Market Growth
- 4.2.3 Factors Challenging the Market
- 4.2.4 Key Companies
- 4.2.5 Application
- 4.2.6 Product
- 4.2.7 North America (by Country)
- 4.2.7.1 U.S.
- 4.2.7.1.1 Market by Application
- 4.2.7.1.2 Market by Product
- 4.2.7.2 Canada
- 4.2.7.2.1 Market by Application
- 4.2.7.2.2 Market by Product
- 4.3 Europe
- 4.3.1 Regional Overview
- 4.3.2 Driving Factors for Market Growth
- 4.3.3 Factors Challenging the Market
- 4.3.4 Key Companies
- 4.3.5 Application
- 4.3.6 Product
- 4.3.7 Europe (by Country)
- 4.3.7.1 Germany
- 4.3.7.1.1 Market by Application
- 4.3.7.1.2 Market by Product
- 4.3.7.2 France
- 4.3.7.2.1 Market by Application
- 4.3.7.2.2 Market by Product
- 4.3.7.3 Italy
- 4.3.7.3.1 Market by Application
- 4.3.7.3.2 Market by Product
- 4.3.7.4 Spain
- 4.3.7.4.1 Market by Application
- 4.3.7.4.2 Market by Product
- 4.3.7.5 U.K.
- 4.3.7.5.1 Market by Application
- 4.3.7.5.2 Market by Product
- 4.3.7.6 Rest-of-Europe
- 4.3.7.6.1 Market by Application
- 4.3.7.6.2 Market by Product
- 4.4 Asia-Pacific
- 4.4.1 Regional Overview
- 4.4.2 Driving Factors for Market Growth
- 4.4.3 Factors Challenging the Market
- 4.4.4 Key Companies
- 4.4.5 Application
- 4.4.6 Product
- 4.4.7 Asia-Pacific (by Country)
- 4.4.7.1 China
- 4.4.7.1.1 Market by Application
- 4.4.7.1.2 Market by Product
- 4.4.7.2 Japan
- 4.4.7.2.1 Market by Application
- 4.4.7.2.2 Market by Product
- 4.4.7.3 India
- 4.4.7.3.1 Market by Application
- 4.4.7.3.2 Market by Product
- 4.4.7.4 South Korea
- 4.4.7.4.1 Market by Application
- 4.4.7.4.2 Market by Product
- 4.4.7.5 Rest-of-Asia-Pacific
- 4.4.7.5.1 Market by Application
- 4.4.7.5.2 Market by Product
- 4.5 Rest-of-the-World
- 4.5.1 Regional Overview
- 4.5.2 Driving Factors for Market Growth
- 4.5.3 Factors Challenging the Market
- 4.5.4 Key Companies
- 4.5.5 Application
- 4.5.6 Product
- 4.5.7 Rest-of-the-World (by Region)
- 4.5.7.1 South America
- 4.5.7.1.1 Market by Application
- 4.5.7.1.2 Market by Product
- 4.5.7.2 Middle East and Africa
- 4.5.7.2.1 Market by Application
- 4.5.7.2.2 Market by Product
5. Markets - Competitive Benchmarking & Company Profiles
- 5.1 Next Frontiers
- 5.2 Geographic Assessment
- 5.3 Company Profiles
- 5.3.1 Medtronic
- 5.3.1.1 Overview
- 5.3.1.2 Top Products/Product Portfolio
- 5.3.1.3 Top Competitors
- 5.3.1.4 Target Customers
- 5.3.1.5 Key Personnel
- 5.3.1.6 Analyst View
- 5.3.1.7 Market Share
- 5.3.2 Novozymes
- 5.3.2.1 Overview
- 5.3.2.2 Top Products/Product Portfolio
- 5.3.2.3 Top Competitors
- 5.3.2.4 Target Customers
- 5.3.2.5 Key Personnel
- 5.3.2.6 Analyst View
- 5.3.2.7 Market Share
- 5.3.3 BASF SE
- 5.3.3.1 Overview
- 5.3.3.2 Top Products/Product Portfolio
- 5.3.3.3 Top Competitors
- 5.3.3.4 Target Customers
- 5.3.3.5 Key Personnel
- 5.3.3.6 Analyst View
- 5.3.3.7 Market Share
- 5.3.4 DuPont
- 5.3.4.1 Overview
- 5.3.4.2 Top Products/Product Portfolio
- 5.3.4.3 Top Competitors
- 5.3.4.4 Target Customers
- 5.3.4.5 Key Personnel
- 5.3.4.6 Analyst View
- 5.3.4.7 Market Share
- 5.3.5 Cargill, Inc.
- 5.3.5.1 Overview
- 5.3.5.2 Top Products/Product Portfolio
- 5.3.5.3 Top Competitors
- 5.3.5.4 Target Customers
- 5.3.5.5 Key Personnel
- 5.3.5.6 Analyst View
- 5.3.5.7 Market Share
- 5.3.6 Royal DSM N.V.
- 5.3.6.1 Overview
- 5.3.6.2 Top Products/Product Portfolio
- 5.3.6.3 Top Competitors
- 5.3.6.4 Target Customers
- 5.3.6.5 Key Personnel
- 5.3.6.6 Analyst View
- 5.3.6.7 Market Share
- 5.3.7 Archer Daniles Midland Company
- 5.3.7.1 Overview
- 5.3.7.2 Top Products/Product Portfolio
- 5.3.7.3 Top Competitors
- 5.3.7.4 Target Customers
- 5.3.7.5 Key Personnel
- 5.3.7.6 Analyst View
- 5.3.7.7 Market Share
- 5.3.8 BioAmber Inc.
- 5.3.8.1 Overview
- 5.3.8.2 Top Products/Product Portfolio
- 5.3.8.3 Top Competitors
- 5.3.8.4 Target Customers
- 5.3.8.5 Key Personnel
- 5.3.8.6 Analyst View
- 5.3.8.7 Market Share
- 5.3.9 Lesaffre
- 5.3.9.1 Overview
- 5.3.9.2 Top Products/Product Portfolio
- 5.3.9.3 Top Competitors
- 5.3.9.4 Target Customers
- 5.3.9.5 Key Personnel
- 5.3.9.6 Analyst View
- 5.3.9.7 Market Share
- 5.3.10 Corbion N.V.
- 5.3.10.1 Overview
- 5.3.10.2 Top Products/Product Portfolio
- 5.3.10.3 Top Competitors
- 5.3.10.4 Target Customers
- 5.3.10.5 Key Personnel
- 5.3.10.6 Analyst View
- 5.3.10.7 Market Share
- 5.3.11 Evonik Industries AG
- 5.3.11.1 Overview
- 5.3.11.2 Top Products/Product Portfolio
- 5.3.11.3 Top Competitors
- 5.3.11.4 Target Customers
- 5.3.11.5 Key Personnel
- 5.3.11.6 Analyst View
- 5.3.11.7 Market Share
- 5.3.12 Genomatica, Inc
- 5.3.12.1 Overview
- 5.3.12.2 Top Products/Product Portfolio
- 5.3.12.3 Top Competitors
- 5.3.12.4 Target Customers
- 5.3.12.5 Key Personnel
- 5.3.12.6 Analyst View
- 5.3.12.7 Market Share
- 5.3.13 Ginkgo Bioworks
- 5.3.13.1 Overview
- 5.3.13.2 Top Products/Product Portfolio
- 5.3.13.3 Top Competitors
- 5.3.13.4 Target Customers
- 5.3.13.5 Key Personnel
- 5.3.13.6 Analyst View
- 5.3.13.7 Market Share
- 5.3.14 Amyris Inc.
- 5.3.14.1 Overview
- 5.3.14.2 Top Products/Product Portfolio
- 5.3.14.3 Top Competitors
- 5.3.14.4 Target Customers
- 5.3.14.5 Key Personnel
- 5.3.14.6 Analyst View
- 5.3.14.7 Market Share
- 5.3.15 TerraVia Holdings, Inc
- 5.3.15.1 Overview
- 5.3.15.2 Top Products/Product Portfolio
- 5.3.15.3 Top Competitors
- 5.3.15.4 Target Customers
- 5.3.15.5 Key Personnel
- 5.3.15.6 Analyst View
- 5.3.15.7 Market Share
- 5.4 Other Key Companies
6. Research Methodology
°ü·ÃÀÚ·á